Try a single issue or save on a subscription Issues delivered straight to your door or device ...

There are many consequences of untreated OSA, and all of these are more likely with more-severe obstruction. Because people ...

Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...

Patients with Hidradenitis Suppurativa (HS) are at a significantly higher risk of obstructive sleep apnea (OSA) compared to ...

The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with obesity.

The FDA approved the phase 2 Explore-OSA trial set to assess the highly selective aldosterone synthase inhibitor, ...

Obstructive sleep apnea (OSA) is associated with an increased risk for cardiovascular disease (CVD) in adults, even those younger than 40 years, according to a study published online June 6 in the ...

Sleep apnea, both obstructive sleep apnea (OSA) and central sleep apnea (CSA), can also cause loud snoring. This is a sleep ...

Sleep apnea is a condition that causes repeated cycles of breathing interruptions during sleep. If left untreated, sleep apnea may lead to dangerous health complications related to oxygen deprivation.

Rising prevalence of sleep apnea, technological advancements in treatment devices, and increasing public awareness drive robust growth in the sleep apnea devices Market.Pune, Jan. 21, 2025 (GLOBE ...

Averaging up to 20% of weight loss, adults taking Tirzepatide had at least 25 fewer breathing interruptions each hour as they ...